Related Experiment Video
Updated: Jun 8, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
Involvement of membrane type 1-matrix metalloproteinase (MT1-MMP) in RAGE activation signaling pathways
Masashi Kamioka1, Toshiyuki Ishibashi, Hiroshi Ohkawara
1Department of Cardiology and Hematology, Fukushima Medical University, Fukushima, Japan.
Abstract:
An advanced glycation end products (AGE)/a receptor for AGE (RAGE) axis plays a key role in diabetic vascular complications. Membrane type 1-matrix metalloproteinase (MT1-MMP) has been shown to function not only as a proteolytic enzyme but also as a signaling molecule. In this study, we investigated the role of MT1-MMP in the AGE/RAGE-triggered signaling pathways in cultured rabbit smooth muscle cells (SMCs) and the molecular interaction between RAGE and MT1-MMP in vitro and in vivo. In SMCs, AGE-activated Rac1 and p47(phox) within 1 min, NADPH oxidase activity and reactive oxygen species (ROS) generation within 5 min, and NF-κB phosphorylation within 15 min, thereby inducing redox-sensitive molecular expression. Silencing of RAGE by small-interfering RNA (siRNA) blocked the AGE-induced signaling pathways. AGE-induced geranylgeranyl transferase I (GGTase I) activity, Rac1·p47(phox) activation, NADPH oxidase activity, ROS generation, and molecular expression were also markedly attenuated by silencing of MT1-MMP. An inhibitor of GGTase I mimicked the effects of MT1-MMP-specific siRNA. Fluorescent immunohistochemistry revealed that MT1-MMP was partially co-localized with RAGE in SMCs, and RAGE was found to form a complex with MT1-MMP in both cultured SMCs and the aortae of diabetic rats by immunoprecipitation. Furthermore, MT1-MMP and RAGE formed a complex in the aortic atherosclerotic lesions of hyperlipidemic rabbits. We show that MT1-MMP plays a crucial role in RAGE-activated NADPH oxidase-dependent signaling pathways and forms a complex with RAGE in the vasculature, thus suggesting that MT1-MMP may be a novel therapeutic target for diabetic vascular complications.
Insights
Advanced glycation end products (AGE) and the receptor for AGE (RAGE) axis contribute to diabetic vascular issues. Membrane type 1-matrix metalloproteinase (MT1-MMP) is crucial in AGE/RAGE signaling pathways, suggesting it as a therapeutic target.
Area of Science:
- Vascular Biology
- Molecular Medicine
- Biochemistry
Background:
- The advanced glycation end products (AGE)/receptor for AGE (RAGE) axis is implicated in diabetic vascular complications.
- Membrane type 1-matrix metalloproteinase (MT1-MMP) acts as both a proteolytic enzyme and a signaling molecule.
Purpose of the Study:
- To investigate the role of MT1-MMP in AGE/RAGE-triggered signaling pathways in smooth muscle cells (SMCs).
- To explore the molecular interaction between RAGE and MT1-MMP in vitro and in vivo.
Main Methods:
- Utilized cultured rabbit SMCs and diabetic rat aortae.
- Employed small-interfering RNA (siRNA) for gene silencing.
- Performed fluorescent immunohistochemistry and immunoprecipitation.
Main Results:
- AGEs activated Rac1, NADPH oxidase, reactive oxygen species (ROS) generation, and NF-κB phosphorylation in SMCs.
- MT1-MMP silencing attenuated AGE-induced signaling, including geranylgeranyl transferase I (GGTase I) activity.
- RAGE and MT1-MMP were found to co-localize and form complexes in SMCs and vascular tissues.
Conclusions:
- MT1-MMP plays a critical role in RAGE-activated NADPH oxidase-dependent signaling pathways.
- MT1-MMP forms a complex with RAGE in the vasculature.
- MT1-MMP represents a potential novel therapeutic target for diabetic vascular complications.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
MAPK Signaling Cascades
Intracellular Signaling Affects Focal Adhesions
Some...
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
